The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medication with broad cardiovascular benefits in those with type 2 diabetes, chronic kidney disease, and heart failure. These include reductions in major adverse cardiac events and cardiovascular death. The mechanisms that underlie the...

Descripción completa

Detalles Bibliográficos
Autores principales: Barraclough, Jennifer Y., Patel, Sanjay, Yu, Jie, Neal, Bruce, Arnott, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534746/
https://www.ncbi.nlm.nih.gov/pubmed/34685677
http://dx.doi.org/10.3390/cells10102699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534746/
https://www.ncbi.nlm.nih.gov/pubmed/34685677
http://dx.doi.org/10.3390/cells10102699

Ejemplares similares